- Home
- INBX vs MLKN Comparison
INBX vs MLKN Comparison
Compare INBX & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INBX | MLKN |
|---|---|---|
| Founded | 2010 | 1905 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2024 | 1994 |
Fundamental Metrics
Financial Performance| Metric | INBX | MLKN |
|---|---|---|
| Price | $100.50 | $20.06 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $150.00 | N/A |
| AVG Volume (30 Days) | 309.3K | ★ 614.2K |
| Earning Date | 05-15-2026 | 03-25-2026 |
| Dividend Yield | N/A | ★ 4.71% |
| EPS Growth | N/A | ★ 344.44 |
| EPS | N/A | ★ 1.32 |
| Revenue | $1,300,000.00 | ★ $3,841,700,000.00 |
| Revenue This Year | N/A | $5.94 |
| Revenue Next Year | N/A | $3.78 |
| P/E Ratio | ★ N/A | $15.02 |
| Revenue Growth | ★ 550.00 | 4.68 |
| 52 Week Low | $28.16 | $13.77 |
| 52 Week High | $155.29 | $24.71 |
Technical Indicators
Market Signals| Indicator | INBX | MLKN |
|---|---|---|
| Relative Strength Index (RSI) | 41.24 | 34.63 |
| Support Level | $99.20 | $19.05 |
| Resistance Level | $106.40 | $20.46 |
| Average True Range (ATR) | 8.26 | 0.90 |
| MACD | -2.20 | -0.16 |
| Stochastic Oscillator | 16.95 | 21.61 |
Price Performance
Historical ComparisonAbout INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.